New horizons in the pharmacological management of venous thromboembolism
Abstract Many patients suffer from venous thromboembolism (VTE) and its consequences. Despite substantial advancements with the introduction of direct oral anticoagulants (DOACs), patients and clinicians still encounter challenges in the acute and long‐term management of VTE, such as recurrent event...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | HemaSphere |
| Online Access: | https://doi.org/10.1002/hem3.70143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|